Bernard Vanhove

Chief Operating Officer at Xenothera SAS

Health Technology

Commercial Services

Consumer Services

Profile

Bernard Vanhove is the founder of Effimune SA, which was founded in 2007.
He is currently the Director of Research at Institut National de la Santé & de la Recherche Médicale, a Research Director at Centre National de la Recherche Scientifique, and the Chief Operating Officer at Xenothera SAS.
He previously worked as the COO and Director-Research & Development at OSE Immunotherapeutics SA from 2016 to 2018.
Dr. Vanhove holds a doctorate degree from Université Catholique de Louvain.

Bernard Vanhove active positions

Companies	Position	Start
Centre National de la Recherche Scientifique Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France.	Corporate Officer/Principal	-
Institut National de la Santé & de la Recherche Médicale Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.	Corporate Officer/Principal	-
Xenothera SAS Xenothera SAS BiotechnologyHealth Technology Xenothera SAS is a biotechnologies company. It creates therapeutic modes in numerous domains from immunomodulation to infectious diseases. The company was founded on June 30, 2014 and is headquartered in	Chief Operating Officer	-

All active positions of Bernard Vanhove

Former positions of Bernard Vanhove

Companies	Position	End
OSE IMMUNOTHERAPEUTICS	Chief Operating Officer	2018-11-30
Effimune SA Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.	Chief Executive Officer	-

See the detail of Bernard Vanhove's experience

Training of Bernard Vanhove

Université Catholique de Louvain

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bernard Vanhove's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
OSE IMMUNOTHERAPEUTICS	Health Technology

Private companies	4
Institut National de la Santé & de la Recherche Médicale Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.	Commercial Services
Centre National de la Recherche Scientifique Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France.	Government
Effimune SA Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.	Health Technology
Xenothera SAS Xenothera SAS BiotechnologyHealth Technology Xenothera SAS is a biotechnologies company. It creates therapeutic modes in numerous domains from immunomodulation to infectious diseases. The company was founded on June 30, 2014 and is headquartered in	Health Technology

See company connections

Stock Market
Insiders
Bernard Vanhove